Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease (vol 16, pg 1747, 2005)
Egile Nagusiak: | Boucheron, C, Desvergnes, V, Compain, P, Martin, O, Lavi, A, Mackeen, M, Wormald, M, Dwek, R, Butters, T |
---|---|
Formatua: | Journal article |
Argitaratua: |
2005
|
Antzeko izenburuak
-
Erratum: Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: The search for new therapeutic agents against Gaucher disease (Tetrahedron: Asymmetry (2005) 16 (1747) DOI: 10.1016/j.tetasy.2005.03. 015)
nork: Boucheron, C, et al.
Argitaratua: (2005) -
Design and synthesis of iminosugar-based inhibitors of glucosylceramide synthase: the search for new therapeutic agents against Gaucher disease
nork: Boucheron, C, et al.
Argitaratua: (2005) -
Can P-glycoprotein influence the bioavailability of iminosugar-based glucosylceramide synthase inhibitors?
nork: Norris-Cervetto, E, et al.
Argitaratua: (2006) -
Selective Targeting of the Interconversion between Glucosylceramide and Ceramide by Scaffold Tailoring of Iminosugar Inhibitors
nork: Cécile Baudoin-Dehoux, et al.
Argitaratua: (2019-01-01) -
Inhibition of glucosylceramide synthase does not reverse drug resistance in cancer cells.
nork: Norris-Cervetto, E, et al.
Argitaratua: (2004)